Thrombin generation and implications for hemophilia therapies: A

Emicizumab and the Clinical Coagulation Laboratory

PDF] Thrombin generation and whole blood viscoelastic assays in

Antithrombin inhibition using nanobodies to correct bleeding in

Pushing the Boundaries of Treatment for Hemophilia A and B

Thrombin generation and implications for hemophilia therapies: A

The effect of emicizumab and bypassing agents in patients with

Advances in the management of haemophilia: emerging treatments and

Thrombin generation for monitoring hemostatic therapy in

Advances in the management of haemophilia: emerging treatments and

Frontiers Thrombin Generation as a Method to Identify the Risk